| Title |
Management of cutaneous T cell lymphoma: new and emerging targets and treatment options
|
|---|---|
| Published in |
Cancer Management and Research, March 2012
|
| DOI | 10.2147/cmar.s9660 |
| Pubmed ID | |
| Authors |
Christiane Querfeld, Janet Y Li, Steven Horwitz, Alison Moskowitz, Patricia L Myskowski, Melissa Pulitzer |
| Abstract |
Cutaneous T cell lymphomas (CTCL) clinically and biologically represent a heterogeneous group of non-Hodgkin lymphomas, with mycosis fungoides and Sézary syndrome being the most common subtypes. Over the last decade, new immunological and molecular pathways have been identified that not only influence CTCL phenotype and growth, but also provide targets for therapies and prognostication. This review will focus on recent advances in the development of therapeutic agents, including bortezomib, the histone deacetylase inhibitors (vorinostat and romidepsin), and pralatrexate in CTCL. |
Twitter Demographics
The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 2% |
| Brazil | 1 | 2% |
| Unknown | 62 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 16 | 25% |
| Student > Bachelor | 10 | 16% |
| Student > Ph. D. Student | 8 | 13% |
| Student > Doctoral Student | 6 | 9% |
| Student > Postgraduate | 6 | 9% |
| Other | 10 | 16% |
| Unknown | 8 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 23 | 36% |
| Biochemistry, Genetics and Molecular Biology | 8 | 13% |
| Agricultural and Biological Sciences | 7 | 11% |
| Nursing and Health Professions | 3 | 5% |
| Chemistry | 3 | 5% |
| Other | 6 | 9% |
| Unknown | 14 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 November 2014.
All research outputs
#17,661,224
of 22,671,366 outputs
Outputs from Cancer Management and Research
#933
of 1,988 outputs
Outputs of similar age
#117,365
of 155,741 outputs
Outputs of similar age from Cancer Management and Research
#8
of 9 outputs
Altmetric has tracked 22,671,366 research outputs across all sources so far. This one is in the 19th percentile – i.e., 19% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,988 research outputs from this source. They receive a mean Attention Score of 2.8. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 155,741 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one.